welcome!
公告:
Speakers(Updating) » Luis G. Gimenez-Lirola


 Luis G. Gimenez-Lirola

Associated Professor in the Department of Veterinary Diagnostic and Production Animal Medicine (VDAPM), College of Veterinary Medicine, Iowa State University. A Biochemist graduated at the University of Granada (Spain), Dr. Gimenez-Lirola obtained a Master of Science degree in Biochemistry at University of Granada, and a PhD in Molecular Biology at Jaen University (Spain). Between 2002 and 2010, he worked for Vircell Microbiologists (Granada, Spain), a biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious diseases in humans, holding different scientific and executive positions. In 2010, Dr Gimenez-Lirola co-founded Rekom Biotech (Granada, Spain), a startup biotech company focused on the design and production of recombinant antigens as biomarkers for infectious and non-infectious diseases. In 2011, he joined Iowa State University Veterinary Diagnostic Laboratory (ISU-VDL) as researcher. During this time, he conducted “whole animal" experimentation toward the assessment, development and/or improvement of diagnostic assays of utility to livestock producers. In 2017, Dr. Gimenez-Lirola become faculty member of the VDPAM at ISU. In 2019, he found Innoceleris LLC., (Iowa, USA) a biotech startup research company specialized in the design and development of ready-to-use diagnostic reagents and assay platforms for emerging zoonotic and animal diseases. Overall, his scientific background and academic education have been orientated to the understanding of the immune response against emerging, re-emerging and zoonotic viral diseases, screening of biomarkers of infection, and development of cost-effective methods to monitor, quantify, and ameliorate the effect of pathogens on animal/human health. Gimenez-Lirola’ s current research is focused on the development of 3D culture models to investigate immunopathogenesis animal pathogens, the characterization of the immune response to emerging infectious diseases, the screening of biomarkers of infection for diagnostic and vaccine development and the isolation and characterization of emerging pathogens with especial emphasis on emerging coronaviruses. He is member of the American Association of Microbiology, the American Society for Virology, the American Association of Veterinary Laboratory Diagnosticians, and the Iowa Veterinary Medical Association.



Return to top